Comparison of Global versus Epidermal Growth Factor Receptor Pathway Profiling for Prediction of Lapatinib Sensitivity in Bladder Cancer

Chemotherapy for metastatic bladder cancer is rarely curative. The recently developed small molecule, lapatinib, a dual epidermal growth factor receptor (EGFR)/human epidermal growth factor receptor-2 receptor tyrosine kinase inhibitor, might improve this situation. Recent findings suggest that iden...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Havaleshko, Dmytro M, Smith, Steven Christopher, Cho, HyungJun, Cheon, Sooyoung, Owens, Charles R, Lee, Jae K, Liotta, Lance A, Espina, Virginia, Wulfkuhle, Julia D, Petricoin, Emanuel F, Theodorescu, Dan
Формат: Статья
Язык:English
Опубликовано: Neoplasia Press Inc. 2009
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2767220/
https://ncbi.nlm.nih.gov/pubmed/19881954
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC2767220/
https://ncbi.nlm.nih.gov/pubmed/19881954

Схожие документы